Clinical research is evolving, but access to trials remains uneven. Many patients still face barriers to participation, and sponsors are searching for new ways to recruit, retain, and reach more diverse communities. Community-based research models have continued to gain momentum as a way to break down these barriers – creating opportunities for more inclusive, efficient, and patient-centered trials. Sponsors are increasingly turning to solutions like mobile sites, virtual visits, and community-based sites to broaden access and unlock the full potential of their studies.

Making trials truly accessible takes partners who can convert these strategies into practical, scalable solutions that work for patients and sponsors alike. EmVenio was founded with a clear mission: to expand the reach of clinical trials by making research more accessible and inclusive. EmVenio brings research closer to patients through mobile and virtual visits, community-based sites, and research centers embedded within existing healthcare facilities, ensuring precise, reliable data across all trial phases, supported by capabilities in more than 80 countries.

In August 2025, PCM Trials and its subsidiaries – EmVenio Research and Clinical Trial Service – aligned under a single name to strengthen their mission of expanding trial access and give partners a seamless platform for scalable, patient-centered research solutions. Looking ahead, sponsors have a unique opportunity to partner with EmVenio and leverage a proven platform of community-based solutions that expand reach, drive recruitment, and improve retention.

Connect with EmVenio at SCOPE

In February 2026, the SCOPE Summit returns for its 17th annual year, bringing together industry leaders, experts, and innovators for networking opportunities, keynote talks, and panel discussions focused on current challenges and future trends. The event will be held from February 2-5 at Rosen Shingle Creek in Orlando, Florida, and EmVenio will be participating in two speaker sessions detailed below.

Speaker Session #1:

  • Title: ET at Home: Light Years from the Clinic – Designing decentralized trials that meet patients where they are
  • Track: Advancing Trial Delivery
  • Date and Time: Tuesday, February 3rd at 4:20 PM
  • Speakers:
    • Jeff Huntsman, Chief Commercial Officer, EmVenio 
    • Megan Sniecinski, Chief Business Officer, Praxis Precision Medicines

Speaker Session #2:

  • Title: Driving Inclusive Clinical Research Through Community Partnership: Reflections Collective, EmVenio, and Bristol Myers Squibb (Subject to Change)
  • Track: Site Engagement & Operations
  • Date and Time: Wednesday, February 4th at 12:30 PM
  • Speakers:
    • Jeff Huntsman, Chief Commercial Officer, EmVenio
    • Natanya M. Candelario, PharmD, MS, Senior Director, Global Health Equity, Bristol Myers Squibb

Evening reception:

On Tuesday February 3rd from 7-8.30pm, you can also join EmVenio at Rosen Shingle Creek  an evening reception featuring live music and guided tours of one of the company’s community research sites, with drinks and appetizers to be served.

Other conferences in 2026

EmVenio will be attending five Outsourcing in Clinical Trials events in 2026. Please see full details in this article.

For other opportunities to connect with EmVenio in 2026, please further events see below.